JP Morgan Upgrades IBM to Overweight, Raises Price Target to $291

Benzinga Newsdesk www.benzinga.com Positive 80.5%

Neg 0% Neu 0% Pos 80.5%

JP Morgan analyst Brian Essex upgrades IBM (NYSE:IBM) from Neutral to Overweight and raises the price target from $270 to $291.